Rho-kinase inhibitors in ophthalmology
Rho-kinase (ROCK) inhibitor is the newer drug available for glaucoma in the Indian market. It seems to target the actual area of disease pathology which has not been the case with the available medications. With the ever-evolving potential of these drugs in various diseases in ophthalmology, it woul...
I tiakina i:
| Ngā kaituhi matua: | , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Rangatū: | TNOA Journal of Ophthalmic Science and Research |
| Ngā marau: | |
| Urunga tuihono: | http://www.tnoajosr.com/article.asp?issn=2589-4528;year=2021;volume=59;issue=1;spage=56;epage=60;aulast=Gopalakrishna |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|